Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Reid Weyant Merryman, M.D.

Concepts (87)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hodgkin Disease13202313833.590 Why?
Hematopoietic Stem Cell Transplantation18202457532.140 Why?
Lymphoma, Mantle-Cell320232381.420 Why?
Lymphoma, Large B-Cell, Diffuse11202514341.400 Why?
Lymphoma, Follicular220244591.300 Why?
Transplantation, Autologous13202421201.240 Why?
Immunotherapy, Adoptive9202515101.020 Why?
Lymphoma, Non-Hodgkin3202013760.860 Why?
Neoplasm Recurrence, Local12202393730.760 Why?
Neurotoxicity Syndromes120233020.650 Why?
Salvage Therapy4202112720.600 Why?
Immune Evasion120193770.510 Why?
Lymphoma3202318970.510 Why?
Antineoplastic Combined Chemotherapy Protocols102024118680.480 Why?
Antigens, CD19420254430.450 Why?
Stem Cell Transplantation5202316020.420 Why?
Asparaginase120122400.350 Why?
Neoplasm, Residual3202310090.320 Why?
Drug Resistance, Neoplasm2202153370.310 Why?
Antineoplastic Agents32023136480.290 Why?
Leukocytes, Mononuclear2202318570.260 Why?
Transplantation Conditioning4202116350.250 Why?
Combined Modality Therapy3202485290.230 Why?
Schools, Medical120118760.230 Why?
Transplantation, Homologous3202148600.210 Why?
Antibodies, Monoclonal5202392490.210 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma1201215600.210 Why?
Positron-Emission Tomography2202265470.210 Why?
Lymphoma, T-Cell, Peripheral120231250.190 Why?
Humans3720257659680.180 Why?
Disease-Free Survival6202368320.170 Why?
Retrospective Studies142025815140.170 Why?
Immunotherapy3202447520.160 Why?
Education, Medical1201117460.160 Why?
Prognosis42024299220.150 Why?
Health Policy1201126980.150 Why?
Cytarabine120206980.150 Why?
Antibodies, Bispecific120202030.140 Why?
Proto-Oncogene Proteins c-bcl-6120161900.130 Why?
Central Nervous System1202313410.130 Why?
Biological Products120259420.120 Why?
Immunoconjugates120229810.110 Why?
Receptors, Antigen, T-Cell1202325700.110 Why?
Survival Rate42022127950.110 Why?
Graft vs Host Disease2201730780.110 Why?
Clinical Trials as Topic2202080410.110 Why?
Disease Management1202425350.110 Why?
Adult1320252230440.100 Why?
Switzerland220233220.100 Why?
T-Lymphocytes32023102610.090 Why?
Young Adult52024598890.090 Why?
Treatment Outcome62025651880.090 Why?
Statistics, Nonparametric1201728440.090 Why?
Proto-Oncogene Proteins c-myc120169950.090 Why?
Tumor Microenvironment1202339460.090 Why?
Proto-Oncogene Proteins c-bcl-21201614100.080 Why?
Neoplasm Staging12024112060.080 Why?
Molecular Targeted Therapy1202028220.080 Why?
Aged1120251711170.080 Why?
Congresses as Topic220238110.070 Why?
Neoplasms12017223400.070 Why?
CD8-Positive T-Lymphocytes1202146420.070 Why?
Kaplan-Meier Estimate1201764990.060 Why?
Neoplasm Proteins1201835960.060 Why?
Female1220253961120.060 Why?
Middle Aged1020252230090.060 Why?
Methotrexate1201217220.060 Why?
Remission Induction2202424110.060 Why?
Hematologic Neoplasms1201719270.060 Why?
Adolescent52024888350.050 Why?
Male1020253636980.050 Why?
Data Collection1201133180.050 Why?
Follow-Up Studies12021391930.040 Why?
Aged, 80 and over42025594890.040 Why?
Recurrence2202285010.040 Why?
Cohort Studies12020416490.030 Why?
Canada1202021190.030 Why?
Fluorodeoxyglucose F181202220240.030 Why?
Infant12012363860.020 Why?
Child, Preschool12012425000.020 Why?
Prospective Studies22020548020.020 Why?
Survival Analysis12017100700.010 Why?
Gene Expression1201775840.010 Why?
Child12012805640.010 Why?
United States12011729030.010 Why?
Practice Guidelines as Topic1201874250.010 Why?
Quality of Life12020134620.010 Why?
Merryman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (87)
Explore
_
Co-Authors (42)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.